ArticleTranslational animal science2026
Plasma biomarkers for residual feed intake prediction in beef bulls.
Article in Translational animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Role of the Gut-Liver-Kidney Axis in Disease Manifestation and Biomarker Alterations.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Residual feed intake (RFI) is a measure of feed efficiency (FE) independent of growth and body weight (BW), calculated as the difference between actual and expected feed intake (FI) based on mean metabolic weight (MW) and weight gain. We hypothesized that bulls with contrasting RFI differ in plasma concentration of different compounds. RFI was evaluated in 302 bulls from 3 different ranches. After adaptation, bulls consumed the same diet for 56 d, individual FI was daily recorded, BW was measured every 2 weeks, and blood samples were taken at d 0 and 56. The bulls were ranked as low RFI (LRFI) and high RFI (HRFI), and the top and bottom 30 were used for metabolomic, hormone, and isotope analysis. Multivariate and pathway analysis were conducted with MetaboAnalyst, and univariate analysis was conducted with SAS using Mixed procedures. Additionally, for Biomarker analysis, Receiver Operating Characteristic (ROC) curves were constructed with MetaboAnalyst. Sparse Partial Least Squares-Discriminant Analysis (sPLSDA) showed partial cluster separation evidenced by acceptable R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.